Health Trials

PTEN Loss or Low Expression

1

Review clinical trials related to PTEN Loss or Low Expression. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

This is a single-arm, open-label, multicenter, Phase Ib/II clinical trial of CVL237 tablets in combination with serplulimab injection for the treatment of advanced solid tumors with PTEN loss or low expression

Participants needed: 180
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Convalife (Shanghai) Co., Ltd.Updated: Mar 3, 2026
Eligibility criteria

Aged 18 to 75 years (inclusive of both endpoints), regardless of gender； [+7]

Surgery or Trauma: Undergone major organ surgery or experienced significant trau... [+20]

Read more